{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:20:25Z","timestamp":1792290025568,"version":"4.4.0"},"reference-count":114,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1979,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1002\/hep.23472","type":"journal-article","created":{"date-parts":[[2009,11,30]],"date-time":"2009-11-30T20:03:22Z","timestamp":1259611402000},"page":"1095-1106","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":28,"title":["Biliary physiology and disease"],"prefix":"10.1097","volume":"51","author":[{"given":"Gustav","family":"Paumgartner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20250312","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0014-4800(68)90032-4","article-title":"Phagocytic activity in experimental liver injury","volume":"9","author":"Paumgartner","year":"1968","journal-title":"Exp Mol Pathol"},{"key":"R2-1-20250312","first-page":"248","article-title":"Phagocytic activity and hepatic function following localized proton radiation to the liver","volume":"38","author":"Paumgartner","year":"1967","journal-title":"Aerosp Med"},{"key":"R3-1-20250312","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1001\/jama.1967.03120160102016","article-title":"Indocyanine green clearance as a test for hepatic function","volume":"200","author":"Leevy","year":"1967","journal-title":"JAMA"},{"key":"R4-1-20250312","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/BF01900289","article-title":"Kinetik der hepatischen farbstoffaufnahme von indocyaningruen. Einfluss von bilirubin und natriumglykocholat","volume":"25","author":"Paumgartner","year":"1969","journal-title":"Experientia"},{"key":"R5-1-20250312","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1749-6632.1970.tb37009.x","article-title":"Kinetics of indocyanine green removal from the blood","volume":"170","author":"Paumgartner","year":"1970","journal-title":"Ann N Y Acad Sci"},{"key":"R6-1-20250312","first-page":"1","article-title":"The handling of indocyanine green by the liver","volume":"105","author":"Paumgartner","year":"1975","journal-title":"Schweiz Med Wochenschr"},{"key":"R7-1-20250312","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/bjs.5258","article-title":"Perioperative real\u2010time monitoring of indocyanine green clearance by pulse spectrophotometry predicts remnant liver functional reserve in resection of hepatocellular carcinoma","volume":"93","author":"Ohwada","year":"2006","journal-title":"Br J Surg"},{"key":"R8-1-20250312","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/MCC.0b013e328012b268","article-title":"Assessing liver function","volume":"13","author":"Sakka","year":"2007","journal-title":"Curr Opin Crit Care"},{"key":"R9-1-20250312","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s11605-008-0564-1","article-title":"Quantitative assessment of hepatic function and its relevance to the liver surgeon","volume":"13","author":"Morris\u2010Stiff","year":"2009","journal-title":"J Gastrointest Surg"},{"key":"R10-1-20250312","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1002\/lt.21841","article-title":"Early noninvasive measurement of the indocyanine green plasma disappearance rate accurately predicts early graft dysfunction and mortality after deceased donor liver transplantation","volume":"15","author":"Olmedilla","year":"2009","journal-title":"Liver Transpl"},{"key":"R11-1-20250312","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0016-5085(73)80013-7","article-title":"Inhibition of bile salt\u2010independent bile formation by indocyanine green","volume":"64","author":"Horak","year":"1973","journal-title":"Gastroenterology"},{"key":"R12-1-20250312","first-page":"344","article-title":"Das verhalten konjugierter gallensaueren des serums bei erkrankungen der leber","volume":"17","author":"Paumgartner","year":"1969","journal-title":"Acta Hepatosplenol"},{"key":"R13-1-20250312","first-page":"171","article-title":"Die serumkonzentrationen konjugierter gallensaeuren beim nichthaemolitischen ikterus","volume":"50","author":"Paumgartner","year":"1969","journal-title":"Wien Z inn Med"},{"key":"R14-1-20250312","first-page":"384","article-title":"Die indocyaningruen\u2010clearance beim Dublin\u2010Johnson\u2010Syndrom","volume":"7","author":"Paumgartner","year":"1969","journal-title":"Z Gastroenterol"},{"key":"R15-1-20250312","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0016-5085(75)80057-6","article-title":"Kinetics of taurocholate uptake by the perfused rat liver","volume":"68","author":"Reichen","year":"1975","journal-title":"Gastroenterology"},{"key":"R16-1-20250312","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/BF01922553","article-title":"Different pathways for hepatic uptake of taurocholate and indocyanine green","volume":"31","author":"Paumgartner","year":"1975","journal-title":"Experientia"},{"key":"R17-1-20250312","first-page":"169","article-title":"Kinetics of hepatic uptake of unconjugated bilirubin","volume":"51","author":"Paumgartner","year":"1976","journal-title":"Clin Sci Mol Med"},{"key":"R18-1-20250312","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1152\/ajplegacy.1976.231.3.734","article-title":"Uptake of bile acids by perfused rat liver","volume":"231","author":"Reichen","year":"1976","journal-title":"Am J Physiol"},{"key":"R19-1-20250312","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1007\/BF01955131","article-title":"Disparate Na+\u2010requirement of taurocholate and indocyanine green uptake by isolated hepatocytes","volume":"35","author":"Minder","year":"1979","journal-title":"Experientia"},{"key":"R20-1-20250312","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF00501151","article-title":"Taurocholate excretion and bile formation in the isolated perfused rat liver. An in vitro \u2010in vivo comparison","volume":"285","author":"Paumgartner","year":"1974","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"R21-1-20250312","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1080\/00365521.1976.12097181","article-title":"Inhibition of bile formation by high doses of taurocholate in the perfused rat liver","volume":"11","author":"Herz","year":"1976","journal-title":"Scand J Gastroenterol"},{"key":"R22-1-20250312","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF00632636","article-title":"Effect of phenobarbital, spironolactone and pregnenolone\u201016 alpha\u2010carbonitrile on bile formation in the rat","volume":"287","author":"von Bergmann","year":"1975","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"R23-1-20250312","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1365-2362.1974.tb00396.x","article-title":"Bile salt metabolism and bile formation in the rat with a protacaval shunt","volume":"4","author":"Herz","year":"1974","journal-title":"Eur J Clin Invest"},{"key":"R24-1-20250312","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cmet.2005.09.001","article-title":"Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis","volume":"2","author":"Inagaki","year":"2005","journal-title":"Cell Metab"},{"key":"R25-1-20250312","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1053\/j.gastro.2003.06.005","article-title":"Enterohepatic bile salt transporters in normal physiology and liver disease","volume":"126","author":"Kullak\u2010Ublick","year":"2004","journal-title":"Gastroenterology"},{"key":"R26-1-20250312","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s00424-003-1130-z","article-title":"The sodium bile salt cotransport family SLC10","volume":"447","author":"Hagenbuch","year":"2004","journal-title":"Pflugers Arch"},{"key":"R27-1-20250312","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0005-2736(02)00633-8","article-title":"The superfamily of organic anion transporting polypeptides","volume":"1609","author":"Hagenbuch","year":"2003","journal-title":"Biochim Biophys Acta"},{"key":"R28-1-20250312","doi-asserted-by":"crossref","first-page":"9626","DOI":"10.1074\/jbc.M004968200","article-title":"Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6","volume":"276","author":"Cui","year":"2001","journal-title":"J Biol Chem"},{"key":"R29-1-20250312","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0168-8278(96)80307-2","article-title":"Assignment of the human organic anion transporting polypeptide (OATP) gene to chromosome 12p12 by fluorescence in situ hybridization","volume":"25","author":"Kullak\u2010Ublick","year":"1996","journal-title":"J Hepatol"},{"key":"R30-1-20250312","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/hep.510260429","article-title":"Identification and functional characterization of the promoter region of the human organic anion transporting polypeptide gene","volume":"26","author":"Kullak\u2010Ublick","year":"1997","journal-title":"HEPATOLOGY"},{"key":"R31-1-20250312","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00424-006-0152-8","article-title":"The bile salt export pump","volume":"453","author":"Stieger","year":"2007","journal-title":"Pflugers Arch"},{"key":"R32-1-20250312","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00424-006-0109-y","article-title":"The apical conjugate efflux pump ABCC2 (MRP2)","volume":"453","author":"Nies","year":"2007","journal-title":"Pflugers Arch"},{"key":"R33-1-20250312","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1002\/hep.510230519","article-title":"Absence of the canalicular isoform of the MRP gene\u2010encoded conjugate export pump from the hepatocytes in Dubin\u2010Johnson syndrome","volume":"23","author":"Kartenbeck","year":"1996","journal-title":"HEPATOLOGY"},{"key":"R34-1-20250312","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/hep.510250635","article-title":"A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin\u2010Johnson syndrome","volume":"25","author":"Paulusma","year":"1997","journal-title":"HEPATOLOGY"},{"key":"R35-1-20250312","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1152\/physrev.00027.2002","article-title":"Bile salt transporters: molecular characterization, function, and regulation","volume":"83","author":"Trauner","year":"2003","journal-title":"Physiol Rev"},{"key":"R36-1-20250312","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1021\/mp060010s","article-title":"Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations","volume":"3","author":"Zollner","year":"2006","journal-title":"Mol Pharm"},{"key":"R37-1-20250312","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.3748\/wjg.v12.i28.4445","article-title":"Medical treatment of cholestatic liver diseases: from pathobiology to pharmacological targets","volume":"12","author":"Paumgartner","year":"2006","journal-title":"World J Gastroenterol"},{"key":"R38-1-20250312","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cld.2007.11.013","article-title":"Medical treatment of cholestatic liver disease","volume":"12","author":"Paumgartner","year":"2008","journal-title":"Clin Liver Dis"},{"key":"R39-1-20250312","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jhep.2009.05.012","article-title":"New molecular insights into the mechanisms of cholestasis","volume":"51","author":"Wagner","year":"2009","journal-title":"J Hepatol"},{"key":"R40-1-20250312","doi-asserted-by":"crossref","first-page":"28857","DOI":"10.1074\/jbc.M011610200","article-title":"Human bile salt export pump promoter is transactivated by the farnesoid X receptor\/bile acid receptor","volume":"276","author":"Ananthanarayanan","year":"2001","journal-title":"J Biol Chem"},{"key":"R41-1-20250312","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1074\/jbc.M109326200","article-title":"Regulation of multidrug resistance\u2010associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X\u2010activated receptor, and constitutive androstane receptor","volume":"277","author":"Kast","year":"2002","journal-title":"J Biol Chem"},{"key":"R42-1-20250312","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/hep.22771","article-title":"High expression of the bile salt\u2010homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis","volume":"49","author":"Schaap","year":"2009","journal-title":"HEPATOLOGY"},{"key":"R43-1-20250312","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/hep.1840060110","article-title":"Prognostic significance of serum bile acids in cirrhosis","volume":"6","author":"Mannes","year":"1986","journal-title":"HEPATOLOGY"},{"key":"R44-1-20250312","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/0140-6736(91)91972-W","article-title":"Gallstones: pathogenesis","volume":"338","author":"Paumgartner","year":"1991","journal-title":"Lancet"},{"key":"R46-1-20250312","doi-asserted-by":"crossref","first-page":"16237","DOI":"10.1073\/pnas.252582399","article-title":"Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion","volume":"99","author":"Yu","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R47-1-20250312","doi-asserted-by":"crossref","first-page":"8742","DOI":"10.1074\/jbc.M411080200","article-title":"Expression of ABCG5 and ABCG8 is required for regulation of biliary cholesterol secretion","volume":"280","author":"Yu","year":"2005","journal-title":"J Biol Chem"},{"key":"R48-1-20250312","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0016-5085(85)90328-2","article-title":"Biliary lipid output and bile acid kinetics in cholesterol gallstone disease. Evidence for an increased hepatic secretion of cholesterol in Swedish patients","volume":"89","author":"Nilsell","year":"1985","journal-title":"Gastroenterology"},{"key":"R49-1-20250312","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2796.2007.01783.x","article-title":"Gallstone disease","volume":"261","author":"Marschall","year":"2007","journal-title":"J Intern Med"},{"key":"R50-1-20250312","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/hep.20654","article-title":"Genetic and environmental influences on symptomatic gallstone disease: a Swedish study of 43,141 twin pairs","volume":"41","author":"Katsika","year":"2005","journal-title":"HEPATOLOGY"},{"key":"R51-1-20250312","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/hep.21847","article-title":"Increased gallstone risk in humans conferred by common variant of hepatic ATP\u2010binding cassette transporter for cholesterol","volume":"46","author":"Grunhage","year":"2007","journal-title":"HEPATOLOGY"},{"key":"R52-1-20250312","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/ng2101","article-title":"A genome\u2010wide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone disease","volume":"39","author":"Buch","year":"2007","journal-title":"Nat Genet"},{"key":"R53-1-20250312","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/gut.29.4.522","article-title":"Deoxycholic acid and the pathogenesis of gall stones","volume":"29","author":"Marcus","year":"1988","journal-title":"Gut"},{"key":"R54-1-20250312","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S0022-2275(20)34446-1","article-title":"Simultaneous determination of cholic acid and chenodeoxycholic acid pool sizes and fractional turnover rates in human serum using 13C\u2010labeled bile acids","volume":"25","author":"Stellaard","year":"1984","journal-title":"J Lipid Res"},{"key":"R55-1-20250312","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/S0022-2275(20)38758-7","article-title":"Determination of deoxycholic acid pool size and input rate using 24\u201013C deoxycholic acid and serum sampling","volume":"27","author":"Stellaard","year":"1987","journal-title":"J Lipid Res"},{"key":"R56-1-20250312","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/bms.1200141106","article-title":"Simultaneous determination of pool sizes and fractional turnover rates of deoxycholic acid, cholic acid and chenodeoxycholic acid in man by isotope dilution with 2H and 13C lables and serum sampling","volume":"14","author":"Stellaard","year":"1987","journal-title":"Biomed Environ Mass Spectrom"},{"key":"R57-1-20250312","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1172\/JCI115961","article-title":"Disorders of bile acid metabolism in cholesterol gallstone disease","volume":"90","author":"Berr","year":"1992","journal-title":"J Clin Invest"},{"key":"R58-1-20250312","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/S0016-5085(96)70024-0","article-title":"7 alpha\u2010dehydroxylating bacteria enhance deoxycholic acid input and cholesterol saturation of bile in patients with gallstones","volume":"111","author":"Berr","year":"1996","journal-title":"Gastroenterology"},{"key":"R59-1-20250312","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM197201062860101","article-title":"Dissolution of cholesterol gallstones by chenodeoxycholic acid","volume":"286","author":"Danzinger","year":"1972","journal-title":"N Engl J Med"},{"key":"R61-1-20250312","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/21548331.1975.11946380","article-title":"Pharmacokinetic aspects of chenodeoxycholic acid therapy","volume":"10","author":"Paumgartner","year":"1975","journal-title":"Hosp Pract"},{"key":"R62-1-20250312","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2362.1983.tb00126.x","article-title":"Portal\u2010systemic spill\u2010over of bile acids: a study of mechanisms using ursodeoxycholic acid","volume":"13","author":"Miescher","year":"1983","journal-title":"Eur J Clin Invest"},{"key":"R63-1-20250312","first-page":"413","article-title":"Die konjugation von chenodesoxycholsaeure und cholsaeure waehrend einer leberpassage","volume":"105","author":"von Bergmann","year":"1975","journal-title":"Schweiz Med Wochenschr"},{"key":"R64-1-20250312","first-page":"690","article-title":"Dissolution of cholesterol gallstones by long\u2010term administration of ursodeoxycholic acid","volume":"72","author":"Makino","year":"1975","journal-title":"Jpn J Gastroenterol"},{"key":"R65-1-20250312","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0140-6736(77)90301-4","article-title":"Dissolution of cholesterol gallstones by ursodeoxycholic acid","volume":"2","author":"Nakagawa","year":"1977","journal-title":"Lancet"},{"key":"R67-1-20250312","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJM198603273141304","article-title":"Fragmentation of gallstones by extracorporeal shock waves","volume":"314","author":"Sauerbruch","year":"1986","journal-title":"N Engl J Med"},{"key":"R68-1-20250312","doi-asserted-by":"crossref","first-page":"347","DOI":"10.7326\/0003-4819-107-2-347","article-title":"Extracorporal shock\u2010wave lithotripsy of gallstones without general anesthesia: first clinical experience","volume":"107","author":"Sackmann","year":"1987","journal-title":"Ann Intern Med"},{"key":"R69-1-20250312","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJM198802183180701","article-title":"Shock\u2010wave lithotripsy of gallbladder stones. The first 175 patients","volume":"318","author":"Sackmann","year":"1988","journal-title":"N Engl J Med"},{"key":"R70-1-20250312","doi-asserted-by":"crossref","first-page":"290","DOI":"10.7326\/0003-4819-114-4-290","article-title":"Results of the first 5 years with 711 patients","volume":"114","author":"Sackmann","year":"1991","journal-title":"Ann Intern Med"},{"key":"R71-1-20250312","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0168-8278(05)80522-7","article-title":"Gallbladder emptying is an important factor in fragment disappearance after shock wave lithotripsy","volume":"17","author":"Sackmann","year":"1993","journal-title":"J Hepatol"},{"key":"R72-1-20250312","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/0016-5085(94)90555-X","article-title":"Gallbladder emptying determines early gallstone clearance after shock\u2010wave lithotripsy","volume":"107","author":"Pauletzki","year":"1994","journal-title":"Gastroenterology"},{"key":"R74-1-20250312","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/0016-5085(90)90830-T","article-title":"Early gallstone recurrence rate after successful shock\u2010wave therapy","volume":"98","author":"Sackmann","year":"1990","journal-title":"Gastroenterology"},{"key":"R75-1-20250312","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0016-5085(94)95581-6","article-title":"Gallstone recurrence after shock\u2010wave therapy","volume":"106","author":"Sackmann","year":"1994","journal-title":"Gastroenterology"},{"key":"R76-1-20250312","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1053\/gast.1996.v111.pm8780583","article-title":"Gallbladder emptying and gallstone formation: a prospective study on gallstone recurrence","volume":"111","author":"Pauletzki","year":"1996","journal-title":"Gastroenterology"},{"key":"R77-1-20250312","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0016-5085(94)95519-0","article-title":"Pathogenic factors in early recurrence of cholesterol gallstones","volume":"106","author":"Berr","year":"1994","journal-title":"Gastroenterology"},{"key":"R78-1-20250312","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1136\/gut.35.3.417","article-title":"Pulverisation of calcified and non\u2010calcified gall bladder stones: extracorporeal shock wave lithotripsy used alone","volume":"35","author":"Soehendra","year":"1994","journal-title":"Gut"},{"key":"R79-1-20250312","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0016-5085(97)70042-8","article-title":"Safety and efficacy of repeated shockwave lithotripsy of gallstones with and without adjuvant bile acid therapy","volume":"112","author":"Sauter","year":"1997","journal-title":"Gastroenterology"},{"key":"R80-1-20250312","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/00042737-200505000-00009","article-title":"Extracorporeal shock wave lithotripsy of gallstones: 20th anniversary of the first treatment","volume":"17","author":"Paumgartner","year":"2005","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R81-1-20250312","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0016-5085(89)90775-0","article-title":"Fragmentation of bile duct stones by extracorporeal shock waves. A new approach to biliary calculi after failure of routine endoscopic measures","volume":"96","author":"Sauerbruch","year":"1989","journal-title":"Gastroenterology"},{"key":"R82-1-20250312","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/hep.1840150207","article-title":"Fragmentation of bile duct stones by extracoporeal shock\u2010wave lithotripsy. A five\u2010years experience","volume":"15","author":"Sauerbruch","year":"1992","journal-title":"HEPATOLOGY"},{"key":"R83-1-20250312","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1067\/mge.2001.111042","article-title":"Extracorporeal shock wave lithotripsy for clearance of bile duct stones resistant to endoscopic extraction","volume":"53","author":"Sackmann","year":"2001","journal-title":"Gastrointest Endosc"},{"key":"R84-1-20250312","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1136\/gut.47.5.728","article-title":"Clearance of refractory bile duct stones with extracorporeal shockwave lithotripsy","volume":"47","author":"Ellis","year":"2000","journal-title":"Gut"},{"key":"R85-1-20250312","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1055\/s-2002-33243","article-title":"Impact of gallbladder status on the outcome in patients with retained bile duct stones treated with extracorporeal shockwave lithotripsy","volume":"34","author":"Adamek","year":"2002","journal-title":"Endoscopy"},{"key":"R86-1-20250312","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1055\/s-2007-963437","article-title":"S3\u2010guidelines for diagnosis and treatment of gallstones","volume":"45","author":"Lammert","year":"2007","journal-title":"Z Gastroenterol"},{"key":"R87-1-20250312","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1055\/s-2007-1018284","article-title":"Disintegrtation of a pancreatic duct stone with extracorporeal shock waves in a patient with chronic pancreatitis","volume":"19","author":"Sauerbruch","year":"1987","journal-title":"Endoscopy"},{"key":"R88-1-20250312","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1136\/gut.33.7.969","article-title":"Extracorporeal lithotripsy of pancreatic stones in patients with chronic pancreatitis and pain: A prospective follow up study","volume":"33","author":"Sauerbruch","year":"1992","journal-title":"Gut"},{"key":"R89-1-20250312","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/BF01308413","article-title":"Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow\u2010up. A pilot study","volume":"30","author":"Leuschner","year":"1985","journal-title":"Dig Dis Sci"},{"key":"R90-1-20250312","first-page":"1395","article-title":"The effect of ursodeoxycholic acid on liver function in patients with chronic liver disease","volume":"53","author":"Miyai","year":"1976","journal-title":"Rinsho to Kenkyu"},{"key":"R91-1-20250312","first-page":"2150","article-title":"The examination of the therapeutic efficacy of ursodeoxycholic acid on chronic hepatitis. A double blind study","volume":"64","author":"Yamanaka","year":"1976","journal-title":"Shindan to Chiryo"},{"key":"R93-1-20250312","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S0140-6736(87)91610-2","article-title":"Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?","volume":"1","author":"Poupon","year":"1987","journal-title":"Lancet"},{"key":"R94-1-20250312","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/hep.1840160315","article-title":"Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo\u2010controlled trial","volume":"16","author":"Beuers","year":"1992","journal-title":"HEPATOLOGY"},{"key":"R95-1-20250312","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1056\/NEJM199105303242204","article-title":"A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis","volume":"324","author":"Poupon","year":"1991","journal-title":"N Engl J Med"},{"key":"R96-1-20250312","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1056\/NEJM199703063361003","article-title":"Ursodiol for primary sclerosing cholangitis","volume":"336","author":"Lindor","year":"1997","journal-title":"N Engl J Med"},{"key":"R97-1-20250312","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1053\/j.gastro.2005.08.017","article-title":"High\u2010dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5\u2010year multicenter, randomized, controlled study","volume":"129","author":"Olsson","year":"2005","journal-title":"Gastroenterology"},{"key":"R98-1-20250312","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.23082","article-title":"High\u2010dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis","volume":"50","author":"Lindor","year":"2009","journal-title":"HEPATOLOGY"},{"key":"R99-1-20250312","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1053\/gast.2002.35948","article-title":"Ursodeoxycholic acid aggravates bile infarcts in bile duct\u2010ligated and Mdr2 knockout mice via disruption of cholangioles","volume":"123","author":"Fickert","year":"2002","journal-title":"Gastroenterology"},{"key":"R100-1-20250312","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"Clinical Practice Guidelines: Management of cholestatic liver diseases.","volume":"51","year":"2009","journal-title":"J Hepatol"},{"key":"R101-1-20250312","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/0016-5085(89)91698-3","article-title":"Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double\u2010blind trial","volume":"97","author":"Leuschner","year":"1989","journal-title":"Gastroenterology"},{"key":"R102-1-20250312","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/hep.1840190512","article-title":"The Canadian Multicenter Double\u2010blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis","volume":"19","author":"Heathcote","year":"1994","journal-title":"HEPATOLOGY"},{"key":"R103-1-20250312","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/0016-5085(94)90021-3","article-title":"Ursodeoxycholic acid in the treatment of primary biliary cirrhosis","volume":"106","author":"Lindor","year":"1994","journal-title":"Gastroenterology"},{"key":"R104-1-20250312","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/hep.1840170412","article-title":"Serum bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid therapy","volume":"17","author":"Poupon","year":"1993","journal-title":"HEPATOLOGY"},{"key":"R105-1-20250312","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0168-8278(03)00192-2","article-title":"Combined analysis of the effects of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis","volume":"39","author":"Poupon","year":"2003","journal-title":"J Hepatol"},{"key":"R106-1-20250312","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0168-8278(03)00243-5","article-title":"Ursodeoxycholic acid for primary biliary cirrhosis: treat early to slow progression","volume":"39","author":"Paumgartner","year":"2003","journal-title":"J Hepatol"},{"key":"R107-1-20250312","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0016-5085(97)70183-5","article-title":"Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis","volume":"113","author":"Poupon","year":"1997","journal-title":"Gastroenterology"},{"key":"R108-1-20250312","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1053\/j.gastro.2004.11.009","article-title":"The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis","volume":"128","author":"Corpechot","year":"2005","journal-title":"Gastroenterology"},{"key":"R109-1-20250312","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/j.gastro.2005.12.029","article-title":"Excellent long\u2010term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid","volume":"130","author":"Pares","year":"2006","journal-title":"Gastroenterology"},{"key":"R110-1-20250312","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1111\/j.1572-0241.2006.00699.x","article-title":"Prognosis of ursodeoxycholic Acid\u2010treated patients with primary biliary cirrhosis. Results of a 10\u2010yr cohort study involving 297 patients","volume":"101","author":"ter Borg","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"R111-1-20250312","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"Primary biliary cirrhosis","volume":"50","author":"Lindor","year":"2009","journal-title":"HEPATOLOGY"},{"key":"R112-1-20250312","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/hep.1840150409","article-title":"Effect of ursodeoxycholic acid on the kinetics of the major hydrophobic bile acids in health and in chronic cholestatic liver disease","volume":"15","author":"Beuers","year":"1992","journal-title":"HEPATOLOGY"},{"key":"R113-1-20250312","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/ncpgasthep0521","article-title":"Drug insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis","volume":"3","author":"Beuers","year":"2006","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"R114-1-20250312","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1172\/JCI116921","article-title":"Tauroursodeoxycholic acid stimulates hepatocellular exocytosis and mobilizes extracellular Ca++ mechanisms defective in cholestasis","volume":"92","author":"Beuers","year":"1993","journal-title":"J Clin Invest"},{"key":"R115-1-20250312","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/0016-5085(93)90433-D","article-title":"Effects of tauroursodeoxycholic acid on cytosolic Ca2+ signals in isolated rat hepatocytes","volume":"104","author":"Beuers","year":"1993","journal-title":"Gastroenterology"},{"key":"R116-1-20250312","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1053\/gast.1996.v110.pm8613063","article-title":"Tauroursodeoxycholic acid activates protein kinase C in isolated rat hepatocytes","volume":"110","author":"Beuers","year":"1996","journal-title":"Gastroenterology"},{"key":"R117-1-20250312","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1053\/jhep.2001.24034","article-title":"Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase C\u2010dependent mechanisms in cholestatic rat liver","volume":"33","author":"Beuers","year":"2001","journal-title":"HEPATOLOGY"},{"key":"R118-1-20250312","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/labinvest.3700371","article-title":"Tauroursodeoxycholic acid inserts the bile salt export pump into canalicular membranes of cholestatic rat liver","volume":"86","author":"Dombrowski","year":"2006","journal-title":"Lab Invest"},{"key":"R119-1-20250312","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.gastro.2005.05.009","article-title":"Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans","volume":"129","author":"Marschall","year":"2005","journal-title":"Gastroenterology"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.23472","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201004000-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T11:08:41Z","timestamp":1741777721000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201004000-00001"}},"subtitle":["Reflections of a physician\u2010scientist\u2020"],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":114,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.23472","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}